Further to contractor update CU#231214B on the application process for the NICPLD Independent Prescriber course, and contractor updates CU#231222A and CU#240103A regarding the CPNI DPP survey, a number of further updates are provided below.
SUMMARY
CPNI has been made aware that updated guidance documents and an instructional video on the NICPLD IP training application process have now been added to the NICPLD website.
These resources may be helpful to community pharmacists who are planning to apply during the application window: Monday 22 January 2024, with a closing date of Monday 26 February 2024 at midnight.
In response to early reports from some community pharmacists regarding challenges in relation to obtaining a DPP for IP training, CPNI undertook a survey to gather further information.
The survey has now been extended to 19 January 2024.
ACTION
Contractors are advised to:
Note the updated information provided on the NICPLD website.
Ask all community pharmacist employees who are considering applying for the IP course to complete the CPNI survey as soon as possible, and no later than 19 January 2024.
Please contact a member of the CPNI team should you have any queries.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Contractor
Correspondence regarding the Keep Antibiotics Working Survey has been issued by SPPG 17th January 2024 and can be accessed here.
SUMMARY
Due to the omission of the closure time of the Keep Antibiotics Working survey, it has been agreed with SPPG to re-open the survey on Thursday 18th January 2024 from 9am to 6pm
All future surveys will close at 6pm on the date stated.
ACTION
Contractors who provide the Living Well Service and are yet to complete the survey for Keep Antibiotics Working can access the survey here on 18th January 9am-6pm.
In the event that a survey is not completed, SPPG may seek to recover all, or part of, the associated funding via an adjustment to the pharmacy’s BSO payment account.
Please share this information with all relevant team members.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Contractor,
SPPG issued a letter on 15th January 2024 providing details of the Phased Introduction of Revised Discounting Arrangements that DoH(NI) will apply to prescriptions dispensed from January 2024.
In summary:
the following clawback rates will be introduced:
Discount Scale 1: Generic medicines (excluding those granted a concessionary price) – 18.48%
Discount Scale 2: Appliances – 10.39%
Discount Scale 3: Branded medicines (plus those medicines granted a concessionary price, for the month in which the concessionary price applies) – 5.27%
DoH(NI) will use a phased approach to introduce the new clawback arrangements using both the new rates (referred to above) and the existing clawback arrangements on qualifying medicines and appliances, with the total clawback being calculated and deducted by BSO according to the following ratios:
Jan-Mar’24: 15% using the New rates and 85% using the Existing clawback arrangements.
Apr-June’24: 30% New and 70% Existing.
July-Sept’24: 50% New and 50% Existing.
Oct-Dec’24: 70% New and 30% Existing.
Jan-Mar’25: 85% New and 15% Existing.
April’25 onwards: 100% New and 0% Existing.
This phased approach will be applied to prescriptions dispensed from January 2024 onwards. Under the new arrangements the total amount that will be deducted for each pharmacy will change, by varying amounts, with some pharmacies seeing an increase in the amount deducted and others seeing a reduction.
At this stage you will not have the relevant drug and appliances spend data associated with your pharmacy(-ies) to calculate the impact of the changes should you need to do this for business planning purposes. If you require this, then CPNI recommends that you contact either SPPG or BSO and ask that they retrospectively re-model the discount that was deducted for the pharmacy(-ies) you operated in the 18-month period from June 2022 – November 2023 according to the new clawback rates and the phased approach outlined above. This will enable you to see the impact had the new arrangements been applied during that period and it will provide you with an indicative trend for the clawback going forward.
SPPG acknowledges that CPNI remains opposed to the new discount clawback arrangements within the context of the current level of funding and Drug Tariff arrangements applicable to community pharmacy service provision in Northern Ireland. There are numerous reasons for CPNI’s opposition to the new clawback arrangements and these include the recent announcement in Scotland that the clawback being applied to qualifying branded medicines has been reduced to 1.79%, from December 2023, with the clawback on qualifying generic medicines remaining at 0%.
CPNI appreciates that the information contained within the SPPG letter, as presented, is complex and accordingly further information and clarification will be provided on this and other funding and contractual aspects at a contractor meeting to be arranged in the coming weeks.
Yours sincerely,
SENT ON BEHALF OF GERARD GREENE Chief Executive
Dear Colleague
The Department of Health and Social Care (DHSC) has re-determined the December 2023 concessionary prices for the following medicines:
Drug
Pack Size
Concessionary Price
Aripiprazole 5mg tablets
28
£8.52
Digoxin 125microgram tablets
28
£3.70
Digoxin 250microgram tablets
28
£3.70
Ezetimibe 10mg tablets
28
£17.78 previously £9.44
The new and/or improved prices will apply to prescriptions submitted for payment for the dispensing month of December 2023.
Concessionary prices will be paid against the usual code, no additional endorsements are needed.
Please continue to notify CPNI of any pricing issues you are experiencing via our Medicine Shortage Reporter.
Please bring this to the attention of your pharmacy team(s).
Kind regards
SENT ON BEHALF OF Gerard Greene Chief Executive
Dear Contractor
The survey for the Living Well campaign ‘Keep Antibiotics Working’ is due to close on 15th January 2024.
SUMMARY
The survey for the campaign ‘Keep Antibiotics Working’ survey can be accessed here
Living Well information and resources on the current campaign ‘Take 5 steps to Well Being’ can be accessed here.
ACTION
Contractors who provide the Living Well Service and have yet to complete the online survey for the campaign ‘Keep Antibiotics Working’ can access the survey here.
In the event that a survey is not completed, SPPG may seek to recover all, or part of, the associated funding via an adjustment to the pharmacy’s BSO payment account.
Please be aware from 1st December 2023 to 31st March 2024 a quality assurance pilot on the Living Well service is being undertaken by SPPG. Further information can be accessed from the letter issued by SPPG on 6th November 2023.
For any further information please contact CPNI offices.
Kind regards
SENT ON BEHALF OF GERARD GREENE Chief Executive
WhatsApp Business Terms of Service can be found here and privacy policy hereUCA-NI Privacy Policy We take your privacy seriously and do not share or sell any personal details with third parties for commercial purposes. If you have any questions, please contact the CPNI office. You can withdraw your consent to be contacted at any time by calling 028 9069 0444 or by emailing info@communitypharmacyni.co.uk. CPNI Data Protection Policy and Data Retention policy can be found Click Here
We use cookies on our website to give you the most relevant experience by remembering your preferences and repeat visits. By clicking “Accept”, you consent to the use of ALL the cookies.
This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on your browser as they are essential for the working of basic functionalities of the website. We also use third-party cookies that help us analyze and understand how you use this website. These cookies will be stored in your browser only with your consent. You also have the option to opt-out of these cookies. But opting out of some of these cookies may have an effect on your browsing experience.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.